Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin M Jude

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Journal of the American Chemical Society|May 9, 2008
Structure of a 129Xe-cryptophane biosensor complexed with human carbonic anhydrase IIJulie A Aaron, Jennifer M Chambers, Kevin M Jude, et al.
Immunity|April 14, 2021
The tissue protective functions of interleukin-22 can be decoupled from pro-inflammatory actions through structure-based designRobert A Saxton, Lukas T Henneberg, Marco Calafiore, et al.
Journal of the American Chemical Society|April 5, 2007
Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and IID K Srivastava, Kevin M Jude, Abir L Banerjee, et al.
Journal of the American Chemical Society|March 2, 2006
Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with "two-prong" inhibitors reveal the molecular basis of high affinityKevin M Jude, Abir L Banerjee, Manas K Haldar, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
<i>De novo</i> design and structure of a peptide-centric TCR mimic binding moduleKarsten D Householder, Xinyu Xiang, Kevin M Jude, et al.
Science (New York, N.Y.)|July 24, 2025
De novo design and structure of a peptide-centric TCR mimic binding moduleKarsten D Householder, Xinyu Xiang, Kevin M Jude, et al.
Nature|July 21, 2022
Organizing structural principles of the IL-17 ligand-receptor axisSteven C Wilson, Nathanael A Caveney, Michelle Yen, et al.
Science Immunology|October 25, 2024
Orientation-dependent CD45 inhibition with viral and engineered ligandsMarta T Borowska, Liu D Liu, Nathanael A Caveney, et al.
Nature Biotechnology|January 2, 2023
Facile repurposing of peptide-MHC-restricted antibodies for cancer immunotherapyXinbo Yang, Daisuke Nishimiya, Sara Löchte, et al.
Immunity|May 21, 2015
Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational MechanismsJamie B Spangler, Jakub Tomala, Vincent C Luca, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Journal of the American Chemical Society|May 9, 2008
Structure of a 129Xe-cryptophane biosensor complexed with human carbonic anhydrase IIJulie A Aaron, Jennifer M Chambers, Kevin M Jude, et al.
Immunity|April 14, 2021
The tissue protective functions of interleukin-22 can be decoupled from pro-inflammatory actions through structure-based designRobert A Saxton, Lukas T Henneberg, Marco Calafiore, et al.
Journal of the American Chemical Society|April 5, 2007
Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and IID K Srivastava, Kevin M Jude, Abir L Banerjee, et al.
Journal of the American Chemical Society|March 2, 2006
Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with "two-prong" inhibitors reveal the molecular basis of high affinityKevin M Jude, Abir L Banerjee, Manas K Haldar, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
<i>De novo</i> design and structure of a peptide-centric TCR mimic binding moduleKarsten D Householder, Xinyu Xiang, Kevin M Jude, et al.
Science (New York, N.Y.)|July 24, 2025
De novo design and structure of a peptide-centric TCR mimic binding moduleKarsten D Householder, Xinyu Xiang, Kevin M Jude, et al.
Nature|July 21, 2022
Organizing structural principles of the IL-17 ligand-receptor axisSteven C Wilson, Nathanael A Caveney, Michelle Yen, et al.
Science Immunology|October 25, 2024
Orientation-dependent CD45 inhibition with viral and engineered ligandsMarta T Borowska, Liu D Liu, Nathanael A Caveney, et al.
Nature Biotechnology|January 2, 2023
Facile repurposing of peptide-MHC-restricted antibodies for cancer immunotherapyXinbo Yang, Daisuke Nishimiya, Sara Löchte, et al.
Immunity|May 21, 2015
Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational MechanismsJamie B Spangler, Jakub Tomala, Vincent C Luca, et al.
Pageof 7